Literature DB >> 6156822

Elevated homovanillic acid in cerebrospinal fluid of children with infantile spasms.

M Ito, T Okuno, H Mikawa, Y Osumi.   

Abstract

To determine the role of noradrenaline, dopamine, and serotonin in the brain of patients with infantile spasms, levels of respective major metabolites in cerebrospinal fluid were examined. Homovanillic acid levels were significantly increased in these patients, while 3-methoxy-4-hydroxyphenylethylene glycol and 5-hydroxyindoleacetic acid were not significantly altered, as compared with controls. In patients with febrile convulsion and status epilepticus who were examined during or within a few hours after convulsions the same phenomenon was evident. The increased level of dopamine metabolite was closely related to the occurrrence of convulsions and is considered to be a secondary phenomenon.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156822     DOI: 10.1111/j.1528-1157.1980.tb04086.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  A patient with infantile spasms and low homovanillic acid levels in cerebrospinal fluid: L-dopa dependent seizures?

Authors:  H Sugie; Y Sugie; N Kato; Y Fukuyama
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

2.  Catecholamine level in cerebrospinal fluid of epileptics.

Authors:  M Hiramatsu; N Fujimoto; A Mori
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

Review 3.  Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis.

Authors:  T Z Baram
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

Review 4.  Abnormalities of biogenic amine metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  ACTH and PMX53 recover synaptic transcriptome alterations in a rat model of infantile spasms.

Authors:  Dumitru A Iacobaş; Tamar Chachua; Sanda Iacobaş; Melissa J Benson; Karin Borges; Jana Velíšková; Libor Velíšek
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.